Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2025 07:00 ET | Source: GenVivo, Inc.

GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GEN2 was evaluated in adult patients with advanced solid tumors in an intravenous dose escalation Phase 1 study GEN2 is well-tolerated, with no Dose Limiting Toxicity or treatment-related...
November 06, 2025 08:00 ET | Source: Annovis Bio Inc.

Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program

All 84 sites for pivotal Phase 3 study in early AD are now fully activated, and the first group of patients has completed the 6-month treatment period.
November 06, 2025 07:00 ET | Source: Treos Bio Corp.

TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in Refractory MSS mCRC in JCO Oncology Advances

LONDON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- TREOS Bio today announced the publication in Journal of Clinical Oncology - Oncology Advances of results from OBERTO-201 (NCT05130060), a Phase 1b study...
November 05, 2025 11:32 ET | Source: Research and Markets

Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Focal Segmental Glomerulosclerosis (FSGS) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
November 05, 2025 11:30 ET | Source: Research and Markets

Pustular Psoriasis Global Clinical Trials Market Review 2025: Identify Strategic Trial Sites, Analyze Trial Success Rates, and Gain an Understanding of Market Opportunities

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Pustular Psoriasis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
November 05, 2025 11:28 ET | Source: Research and Markets

Overweight Global Clinical Trials Market Review 2025: Emphasizing the Identification of Key Regions and Prominent Drug Trials

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Overweight - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
November 05, 2025 11:27 ET | Source: Research and Markets

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Market Review 2025: UAE Phase 2 Progress, Microneedle Drug-Delivery Advancements, and FDA Type C Meeting Request

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Basal Cell Carcinoma (Basal Cell Epithelioma) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
November 05, 2025 11:25 ET | Source: Research and Markets

Huntington Disease Global Clinical Trials Market Review 2025: EMA Orphan Drug Designation for SOM3355, Breakthrough Phase 3 Pridopidine Data, and New INGREZZA & Medical Cannabis Advancements (2025)

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Huntington Disease - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
November 05, 2025 11:23 ET | Source: Research and Markets

Herpes Zoster (Shingles) Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Herpes Zoster (Shingles) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
November 05, 2025 11:22 ET | Source: Research and Markets

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, End Point Status

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) - Global Clinical Trials Review, 2025" clinical trials has been added to ...